Managing GLP-1 Side Effects: A Microdosing Perspective
Side effects on GLP-1 medications scale with peak plasma concentration. Microdosing — splitting your weekly dose into daily or every-other-day fractions — keeps plasma levels lower and steadier, dramatically reducing the day-2 nausea spike and fatigue waves that drive many people to quit. Many users who fail standard weekly protocols succeed on a microdose schedule. The strategies below work for both schedules, but microdosers often need lighter intervention.
Note: This article presents research analysis only. Always consult healthcare providers about managing side effects during GLP-1 treatment.
Research Overview
Clinical Data Analysis
According to the SURMOUNT-1 clinical trial (N=2,539), published in the New England Journal of Medicine (2022), side effects are generally mild to moderate and improve with time:
Study Findings
- Nausea: 24.2-31.0%
- Diarrhea: 18.7-23.0%
- Vomiting: 8.4-12.2%
- 95% mild/moderate
Key Insights
- Most effects temporary
- Peak weeks 4-8
- Manageable with support
- Improves over time